Delve Insight
Delve Insight Market Research Reports
| Title | published | price | |
|---|---|---|---|
Palmar Hyperhidrosis - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Palmar Hyperhidrosis- Pipeline Insight, 2022," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Palmar Hyperhidrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and n ... |
31-Mar-2022 | $1500 | |
X linked Adrenoleukodystrophy - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "X linked Adrenoleukodystrophy- Pipeline Insight, 2022," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in X linked Adrenoleukodystrophy pipeline landscape. It covers the pipeline drug profiles, includ ... |
31-Mar-2022 | $1500 | |
Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Cryoprin-Associated Periodic Syndrome- Pipeline Insight, 2022," report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cryoprin-Associated Periodic Syndrome pipeline landscape. It covers the pipeline drug ... |
31-Mar-2022 | $1500 | |
Richter's Syndrome - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Richter's Syndrome- Pipeline Insight, 2022," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Richter's Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... |
31-Mar-2022 | $1500 | |
Thymoma - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Thymoma- Pipeline Insight, 2022," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Thymoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... |
31-Mar-2022 | $1500 | |
Adenoid Cystic Carcinoma - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Adenoid Cystic Carcinoma- Pipeline Insight, 2022" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It covers the pipeline drug profiles, including clinica ... |
31-Mar-2022 | $1500 | |
Blastic Plasmacytoid Dendritic cell neoplasm - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Blastic Plasmacytoid Dendritic cell neoplasm" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Blastic Plasmacytoid Dendritic cell neoplasm pipeline landscape. It covers the pipeline drug profiles, i ... |
31-Mar-2022 | $1500 | |
Nosocomial pneumonia - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Nosocomial pneumonia- Pipeline Insight, 2022" report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in Nosocomial pneumonia pipeline landscape. It covers the pipeline drug profiles, including clinical and ... |
31-Mar-2022 | $1500 | |
Vasculitis - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Vasculitis- Pipeline Insight, 2022," report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Vasculitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... |
31-Mar-2022 | $2000 | |
Chemotherapy Induced Anemia - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Chemotherapy Induced Anemia- Pipeline Insight, 2022," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Chemotherapy Induced Anemia pipeline landscape. It covers the pipeline drug profiles, including ... |
31-Mar-2022 | $1250 | |
Pseudomonal Infections - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Pseudomonal Infections- Pipeline Insight, 2022," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Pseudomonal Infections pipeline landscape. It covers the pipeline drug profiles, including clinical ... |
31-Mar-2022 | $1500 | |
Sensorineural Hearing Loss - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Sensorineural Hearing Loss- Pipeline Insight, 2022," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Sensorineural Hearing Loss pipeline landscape. It covers the pipeline drug profiles, including ... |
31-Mar-2022 | $1500 | |
Chronic Myeloid Leukemia - Pipeline Insight, 2022By Delve Insight
DelveInsight's, "Chronic Myeloid Leukaemia- Pipeline Insight, 2022," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the pipeline drug profiles, including cl ... |
31-Mar-2022 | $2000 | |
Kaposi's sarcoma - Pipeline Insights, 2022By Delve Insight
DelveInsight's, "Kaposi's sarcoma - Pipeline Insight, 2021," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Kaposi's sarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclini ... |
31-Mar-2022 | $1250 | |
Rosacea - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Rosacea - Pipeline Insight, 2021," report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Rosacea pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage produc ... |
12-Oct-2021 | $2000 | |
Carcinoid Syndrome - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Carcinoid Syndrome - Pipeline Insight, 2021," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Carcinoid Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... |
12-Oct-2021 | $1500 | |
Primary ciliary dyskinesia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Primary Ciliary Dyskinesia - Pipeline Insight, 2021," report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Primary Ciliary Dyskinesia pipeline landscape. It covers the pipeline drug profiles, including c ... |
12-Oct-2021 | $1500 | |
Presbyopia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Presbyopia - Pipeline Insight, 2021," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Presbyopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... |
12-Oct-2021 | $1500 | |
Muscle spasticity - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Muscle Spasticity - Pipeline Insight, 2021," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Muscle Spasticity pipeline landscape. It covers the pipeline drug profiles, including clinical and noncli ... |
12-Oct-2021 | $1500 | |
Gaucher's Disease - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Gaucher's Disease - Pipeline Insight, 2021," report provides comprehensive insights about 14+ companies and 16+ pipeline drugs in Gaucher's Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... |
12-Oct-2021 | $1500 | |
- + 1 888 391 5441
- [email protected]
